CapsoVision, Inc (CV) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US1409351079

Price
6.94 USD
Market cap
347.33 m USD
P/E (2025)
–
P/S (2025)
25.63
Dividend yield
0.00 %
Net margin
-186.77 %
Return on equity (ROE)
-190.91 %
Return on assets (ROA)
-139.37 %

CapsoVision, Inc financials

Fiscal year20242025
Revenue11.76 m USD13.55 m USD
Gross profit6.38 m USD7.17 m USD
Operating income-19.92 m USD-25.52 m USD
EBIT-19.89 m USD-25.29 m USD
Net income-19.90 m USD-25.32 m USD
Diluted EPS – continuing operations-9.85 USD-1.03 USD

Full history since 2023, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About CapsoVision, Inc

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.